Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Mesothelioma, Malignant 3Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Metastatic Solid Tumors 1Metastatic NUT Carcinoma 1Melanoma 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Cervical Adenocarcinoma 1Carcinoma, Small Cell 1Carcinoma, Neuroendocrine 1Breast Neoplasms 1Bone Neoplasms 1Advanced NUT Carcinoma 1

Interventions

Cisplatin 2regorafenib 1endostar protein 1alectinib 1Sunitinib 1Plicamycin 1Platinum 1Nivolumab 1Methotrexate 1Metastasectomy 1Ifosfamide 1Epirubicin 1Doxorubicin 1Dacarbazine 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Bone Neoplasms × Platinum × Clear all
NCT03965234 2026-03-17

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

Roswell Park Cancer Institute

Phase 1/2 Recruiting
99 enrolled
GastrointestinalSarcoma

Bone Neoplasms, Sarcoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡